Foundation Fighting Blindness: Translational Research Acceleration Program (TRAP) Award

Research Priority Areas:

(1) Novel Medical Therapies – approaches that use chemistry, biology, and bioengineering to formulate new therapies that mitigate inherited retinal degenerations and dry age-related macular degenerations;

(2) Genetic Technologies – the manipulation and modification of human gene expression to alter the biological properties of living cells/tissues with the goal of providing therapeutic solutions;

(3) Regenerative Medicine – the development, regeneration, and employment of human cells, tissues, and cellular/tissue-based products for the restoration of retinal function and vision.

Funding: $900K- $1.5M for 3 years.

https://www.fightingblindness.org/translational-research-acceleration-program